AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$489M |
| 2 |
PayPal
PYPL
|
+$464M |
| 3 |
Dollar General
DG
|
+$438M |
| 4 |
Synopsys
SNPS
|
+$432M |
| 5 |
MSCI
MSCI
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$887M |
| 2 |
Meta Platforms (Facebook)
META
|
+$589M |
| 3 |
Apple
AAPL
|
+$474M |
| 4 |
Nike
NKE
|
+$451M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 18.36% |
| 3 | Financials | 13.63% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRP.U
2301
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $961K | ﹤0.01% |
18,839
-180
| -0.9% | -$9.61K |
|
2302
Rocket Pharmaceuticals
RCKT
$343M
| $957K | ﹤0.01% |
48,900
| – | – |
|
2303
FIGS
FIGS
$1.73B
| $956K | ﹤0.01% |
142,100
| – | – |
|
2304
iShares S&P Small-Cap 600 Value ETF
IJS
$8.2B
| $955K | ﹤0.01% |
10,463
+573
| +6% | +$52.8K |
|
|
CDMO
2305
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $955K | ﹤0.01% |
69,375
+104
| +0.2% | +$1.59K |
|
2306
Zeta Global
ZETA
$5.46B
| $954K | ﹤0.01% |
116,796
+37,296
| +47% | +$302K |
|
2307
BRC Group Holdings
RILY
$270M
| $954K | ﹤0.01% |
27,885
+38
| +0.1% | +$1.59K |
|
|
AGNT
2308
AGNT Inc
AGNT
$661M
| $952K | ﹤0.01% |
85,953
+2,300
| +3% | +$27.9K |
|
2309
Aclaris Therapeutics
ACRS
$744M
| $951K | ﹤0.01% |
60,400
+14,300
| +31% | +$230K |
|
2310
Kymera Therapeutics
KYMR
$8.73B
| $948K | ﹤0.01% |
38,000
| – | – |
|
2311
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$786M
| $947K | ﹤0.01% |
28,103
+1,329
| +5% | +$45.1K |
|
|
GOOD
2312
Gladstone Commercial Corp
GOOD
$627M
| $943K | ﹤0.01% |
50,984
+13,525
| +36% | +$241K |
|
2313
ACV Auctions
ACVA
$1.43B
| $943K | ﹤0.01% |
114,800
| – | – |
|
2314
B&G Foods
BGS
$297M
| $939K | ﹤0.01% |
84,190
-6,165
| -7% | -$85.7K |
|
2315
Smith & Nephew
SNN
$13.7B
| $937K | ﹤0.01% |
+34,856
| New | +$875K |
|
2316
Titan International
TWI
$530M
| $937K | ﹤0.01% |
61,163
+49
| +0.1% | +$699 |
|
2317
Crinetics Pharmaceuticals
CRNX
$8.88B
| $937K | ﹤0.01% |
51,200
| – | – |
|
2318
Innoviva
INVA
$1.61B
| $934K | ﹤0.01% |
70,519
+66
| +0.1% | +$868 |
|
2319
Construction Partners
ROAD
$6.03B
| $934K | ﹤0.01% |
35,000
+6,200
| +22% | +$178K |
|
2320
C3.ai
AI
$1.38B
| $933K | ﹤0.01% |
83,420
-57
| -0.1% | -$714 |
|
|
SWTX
2321
DELISTED
SpringWorks Therapeutics
SWTX
| $929K | ﹤0.01% |
35,700
| – | – |
|
2322
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.01B
| $928K | ﹤0.01% |
32,617
-5,950
| -15% | -$170K |
|
2323
Schwab US Mid-Cap ETF
SCHM
$14.5B
| $928K | ﹤0.01% |
42,432
-106,623
| -72% | -$2.34M |
|
2324
PC Connection
CNXN
$2.1B
| $919K | ﹤0.01% |
19,586
+6,248
| +47% | +$314K |
|
|
HAPN
2325
Happen Inc
HAPN
$2.19B
| $917K | ﹤0.01% |
104,220
+3,000
| +3% | +$30.9K |
|
Similar funds
AllianceBernstein's Q4 2022 Portfolio in Review
As of Q4 2022, AllianceBernstein held 3,394 positions worth $222B, up 7.6% from $207B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
AllianceBernstein's Q4 2022 filing shows 124 new, 1,572 increased, 1,272 reduced and 134 closed positions. Its largest new stake was Unilever: 2,996,697 shares worth $170M. The largest sale was Alphabet (Google) Class C, an estimated $887M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2022 buy was Unilever: 2,996,697 shares worth $170M.
- AllianceBernstein added most to Illumina in Q4 2022, an estimated $489M increase.
- AllianceBernstein's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $887M.
- AllianceBernstein fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $343M.
- AllianceBernstein's ten largest holdings make up 21% of its $222B portfolio in Q4 2022.
- AllianceBernstein opened 124 new positions and closed 134 in Q4 2022.
- AllianceBernstein's portfolio value rose 7.6% quarter-over-quarter to $222B.
Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.